03.02.20|Lital Dobrovitsky After an acquisition deal with pharmaceutical company InSight fell through in 2018, the company failed to secure further funding
05.07.18|CTechThe deal was announced in March, but intended buyer InSight backed out
28.03.18|Lilach BaumerAs part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials